• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C反应蛋白通过磷酸胆碱依赖性和非磷酸胆碱依赖性机制保护小鼠免受肺炎球菌感染。

C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms.

作者信息

Gang Toh B, Hanley Gregory A, Agrawal Alok

机构信息

Department of Biomedical Sciences, East Tennessee State University, Johnson City, Tennessee, USA.

Division of Laboratory Animal Resources, East Tennessee State University, Johnson City, Tennessee, USA.

出版信息

Infect Immun. 2015 May;83(5):1845-52. doi: 10.1128/IAI.03058-14. Epub 2015 Feb 17.

DOI:10.1128/IAI.03058-14
PMID:25690104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4399050/
Abstract

The mechanism of action of C-reactive protein (CRP) in protecting mice against lethal Streptococcus pneumoniae infection is unknown. The involvement of the phosphocholine (PCh)-binding property of CRP in its antipneumococcal function previously has been explored twice, with conflicting results. In this study, using three different intravenous sepsis mouse models, we investigated the role of the PCh-binding property of CRP by employing a CRP mutant incapable of binding to PCh. The ability of wild-type CRP to protect mice against infection was found to differ in the three models; the protective ability of wild-type CRP decreased when the severity of infection was increased, as determined by measuring mortality and bacteremia. In the first animal model, in which we used 25 μg of CRP and 10(7) CFU of pneumococci, both wild-type and mutant CRP protected mice against infection, suggesting that the protection was independent of the PCh-binding activity of CRP. In the second model, in which we used 25 μg of CRP and 5 × 10(7) CFU of pneumococci, mutant CRP was not protective while wild-type CRP was, suggesting that the protection was dependent on the PCh-binding activity of CRP. In the third model, in which we used 150 μg of CRP and 10(7) CFU of pneumococci, mutant CRP was as protective as wild-type CRP, again indicating that the protection was independent of the PCh-binding activity of CRP. We conclude that both PCh-dependent and PCh-independent mechanisms are involved in the CRP-mediated decrease in bacteremia and the resulting protection of mice against pneumococcal infection.

摘要

C反应蛋白(CRP)保护小鼠免受致死性肺炎链球菌感染的作用机制尚不清楚。此前曾两次探讨CRP的磷酸胆碱(PCh)结合特性在其抗肺炎球菌功能中的作用,结果相互矛盾。在本研究中,我们使用三种不同的静脉脓毒症小鼠模型,通过采用一种无法与PCh结合的CRP突变体,研究了CRP的PCh结合特性的作用。野生型CRP保护小鼠免受感染的能力在三种模型中有所不同;通过测量死亡率和菌血症确定,当感染严重程度增加时,野生型CRP的保护能力下降。在第一个动物模型中,我们使用25μg CRP和10⁷CFU肺炎球菌,野生型和突变型CRP均能保护小鼠免受感染,这表明这种保护与CRP的PCh结合活性无关。在第二个模型中,我们使用25μg CRP和5×10⁷CFU肺炎球菌,突变型CRP没有保护作用,而野生型CRP有保护作用,这表明这种保护依赖于CRP的PCh结合活性。在第三个模型中,我们使用150μg CRP和10⁷CFU肺炎球菌,突变型CRP与野生型CRP的保护作用相同,再次表明这种保护与CRP的PCh结合活性无关。我们得出结论,PCh依赖性和PCh非依赖性机制均参与了CRP介导的菌血症减少以及由此产生的对小鼠肺炎球菌感染的保护作用。

相似文献

1
C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms.C反应蛋白通过磷酸胆碱依赖性和非磷酸胆碱依赖性机制保护小鼠免受肺炎球菌感染。
Infect Immun. 2015 May;83(5):1845-52. doi: 10.1128/IAI.03058-14. Epub 2015 Feb 17.
2
The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infection.C 反应蛋白上的磷酸胆碱结合口袋对于最初保护小鼠免受肺炎球菌感染是必要的。
J Biol Chem. 2012 Dec 14;287(51):43116-25. doi: 10.1074/jbc.M112.427310. Epub 2012 Nov 8.
3
Complement Activation by C-Reactive Protein Is Critical for Protection of Mice Against Pneumococcal Infection.C 反应蛋白通过补体激活对保护小鼠免受肺炎球菌感染至关重要。
Front Immunol. 2020 Aug 13;11:1812. doi: 10.3389/fimmu.2020.01812. eCollection 2020.
4
Structure-Function Relationships of C-Reactive Protein in Bacterial Infection.C 反应蛋白在细菌感染中的结构-功能关系。
Front Immunol. 2019 Feb 26;10:166. doi: 10.3389/fimmu.2019.00166. eCollection 2019.
5
Human C-reactive protein protects mice from Streptococcus pneumoniae infection without binding to pneumococcal C-polysaccharide.人C反应蛋白可保护小鼠免受肺炎链球菌感染,且不与肺炎球菌C多糖结合。
J Immunol. 2007 Jan 15;178(2):1158-1163. doi: 10.4049/jimmunol.178.2.1158.
6
A C-reactive protein mutant that does not bind to phosphocholine and pneumococcal C-polysaccharide.一种不与磷酸胆碱和肺炎球菌C多糖结合的C反应蛋白突变体。
J Immunol. 2002 Sep 15;169(6):3217-22. doi: 10.4049/jimmunol.169.6.3217.
7
Treatment of Pneumococcal Infection by Using Engineered Human C-Reactive Protein in a Mouse Model.利用工程化人 C 反应蛋白在小鼠模型中治疗肺炎球菌感染。
Front Immunol. 2020 Oct 7;11:586669. doi: 10.3389/fimmu.2020.586669. eCollection 2020.
8
Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection.C反应蛋白激活补体经典途径的特性在保护小鼠免受肺炎球菌感染中的作用。
J Immunol. 2006 Apr 1;176(7):4369-74. doi: 10.4049/jimmunol.176.7.4369.
9
Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors.C反应蛋白和天然抗体对肺炎链球菌感染的保护作用需要补体,但不需要Fcγ受体。
J Immunol. 2002 Jun 15;168(12):6375-81. doi: 10.4049/jimmunol.168.12.6375.
10
Blood clearance of Streptococcus pneumoniae by C-reactive protein.C反应蛋白对肺炎链球菌的血液清除作用。
J Immunol. 1987 Apr 15;138(8):2598-603.

引用本文的文献

1
Protection against prolonged pneumococcal infection involves structural changes in C-reactive protein and subsequent binding to both phosphocholine and amyloids on the bacterial surface.对肺炎球菌长期感染的防护涉及C反应蛋白的结构变化以及随后与细菌表面的磷酸胆碱和淀粉样蛋白的结合。
Front Immunol. 2025 Jul 16;16:1631409. doi: 10.3389/fimmu.2025.1631409. eCollection 2025.
2
C-reactive protein: structure, function, regulation, and role in clinical diseases.C 反应蛋白:结构、功能、调节以及在临床疾病中的作用。
Front Immunol. 2024 Jun 14;15:1425168. doi: 10.3389/fimmu.2024.1425168. eCollection 2024.
3
Fc receptors act as innate immune receptors during infection?Fc 受体在感染期间作为先天免疫受体发挥作用?
Front Immunol. 2023 Jul 26;14:1188497. doi: 10.3389/fimmu.2023.1188497. eCollection 2023.
4
The biosynthesis and role of phosphorylcholine in pathogenic and nonpathogenic bacteria.磷酸胆碱的生物合成及其在致病菌和非致病菌中的作用。
Trends Microbiol. 2023 Jul;31(7):692-706. doi: 10.1016/j.tim.2023.01.006. Epub 2023 Feb 28.
5
Deficiency of C-reactive protein or human C-reactive protein transgenic treatment aggravates influenza A infection in mice.缺乏 C-反应蛋白或人 C-反应蛋白转基因治疗可加重小鼠流感 A 感染。
Front Immunol. 2022 Oct 6;13:1028458. doi: 10.3389/fimmu.2022.1028458. eCollection 2022.
6
Structurally Altered, Not Wild-Type, Pentameric C-Reactive Protein Inhibits Formation of Amyloid-β Fibrils.结构改变而非野生型五聚体 C 反应蛋白抑制淀粉样β纤维的形成。
J Immunol. 2022 Sep 15;209(6):1180-1188. doi: 10.4049/jimmunol.2200148. Epub 2022 Aug 17.
7
C-Reactive Protein: Friend or Foe? Phylogeny From Heavy Metals to Modified Lipoproteins and SARS-CoV-2.C反应蛋白:敌还是友?从重金属到修饰脂蛋白及新型冠状病毒2的系统发生
Front Cardiovasc Med. 2022 Mar 24;9:797116. doi: 10.3389/fcvm.2022.797116. eCollection 2022.
8
C-Reactive Protein-Based Strategy to Reduce Antibiotic Dosing for the Treatment of Pneumococcal Infection.基于 C 反应蛋白的策略来减少抗生素剂量以治疗肺炎球菌感染。
Front Immunol. 2021 Jan 20;11:620784. doi: 10.3389/fimmu.2020.620784. eCollection 2020.
9
Treatment of Pneumococcal Infection by Using Engineered Human C-Reactive Protein in a Mouse Model.利用工程化人 C 反应蛋白在小鼠模型中治疗肺炎球菌感染。
Front Immunol. 2020 Oct 7;11:586669. doi: 10.3389/fimmu.2020.586669. eCollection 2020.
10
Complement Activation by C-Reactive Protein Is Critical for Protection of Mice Against Pneumococcal Infection.C 反应蛋白通过补体激活对保护小鼠免受肺炎球菌感染至关重要。
Front Immunol. 2020 Aug 13;11:1812. doi: 10.3389/fimmu.2020.01812. eCollection 2020.

本文引用的文献

1
Human L-ficolin recognizes phosphocholine moieties of pneumococcal teichoic acid.人L-纤维胶凝蛋白可识别肺炎链球菌磷壁酸的磷酸胆碱部分。
J Immunol. 2014 Dec 1;193(11):5699-708. doi: 10.4049/jimmunol.1400127. Epub 2014 Oct 24.
2
Recognition functions of pentameric C-reactive protein in cardiovascular disease.五聚体 C 反应蛋白在心血管疾病中的识别功能。
Mediators Inflamm. 2014;2014:319215. doi: 10.1155/2014/319215. Epub 2014 May 19.
3
C-reactive protein is essential for innate resistance to pneumococcal infection.C-反应蛋白对于先天抵抗肺炎球菌感染是必需的。
Immunology. 2014 Jul;142(3):414-20. doi: 10.1111/imm.12266.
4
Diagnosis of pneumococcal pneumonia: current pitfalls and the way forward.肺炎球菌肺炎的诊断:当前的陷阱与未来方向
Infect Chemother. 2013 Dec;45(4):351-66. doi: 10.3947/ic.2013.45.4.351. Epub 2013 Dec 27.
5
Review of phosphocholine substituents on bacterial pathogen glycans: synthesis, structures and interactions with host proteins.磷酸胆碱取代物在细菌病原体聚糖上的研究进展:合成、结构及与宿主蛋白的相互作用。
Mol Immunol. 2013 Dec;56(4):563-73. doi: 10.1016/j.molimm.2013.05.237. Epub 2013 Aug 1.
6
The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infection.C 反应蛋白上的磷酸胆碱结合口袋对于最初保护小鼠免受肺炎球菌感染是必要的。
J Biol Chem. 2012 Dec 14;287(51):43116-25. doi: 10.1074/jbc.M112.427310. Epub 2012 Nov 8.
7
Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity.诱导细胞和体液免疫的血清型非依赖性肺炎球菌实验性疫苗。
Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3623-7. doi: 10.1073/pnas.1121383109. Epub 2012 Feb 2.
8
Exposing a hidden functional site of C-reactive protein by site-directed mutagenesis.通过定点突变暴露 C 反应蛋白的隐藏功能位点。
J Biol Chem. 2012 Jan 27;287(5):3550-8. doi: 10.1074/jbc.M111.310011. Epub 2011 Dec 9.
9
Requirement for complement in antibody responses is not explained by the classic pathway activator IgM.抗体反应中补体的需求不能用经典途径激活物 IgM 来解释。
Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):E934-42. doi: 10.1073/pnas.1109831108. Epub 2011 Oct 10.
10
Pathogenesis and pathophysiology of pneumococcal meningitis.肺炎球菌性脑膜炎的发病机制和病理生理学。
Clin Microbiol Rev. 2011 Jul;24(3):557-91. doi: 10.1128/CMR.00008-11.